End-of-day quote
Shanghai S.E.
23:00:00 09/05/2024 BST
|
5-day change
|
1st Jan Change
|
7.11
CNY
|
-0.97%
|
|
+4.71%
|
-11.90%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
7,293
|
13,167
|
13,821
|
7,691
|
6,785
|
6,029
|
-
|
-
|
Enterprise Value (EV)
1 |
7,293
|
13,167
|
13,821
|
7,691
|
6,785
|
6,029
|
6,029
|
6,029
|
P/E ratio
|
9.55
x
|
15.3
x
|
16.1
x
|
28.3
x
|
38.4
x
|
18.2
x
|
11.7
x
|
8.89
x
|
Yield
|
-
|
2.13%
|
-
|
-
|
1.16%
|
3.23%
|
4.92%
|
6.61%
|
Capitalization / Revenue
|
0.89
x
|
1.75
x
|
-
|
-
|
0.47
x
|
0.32
x
|
0.27
x
|
0.26
x
|
EV / Revenue
|
0.89
x
|
1.75
x
|
-
|
-
|
0.47
x
|
0.32
x
|
0.27
x
|
0.26
x
|
EV / EBITDA
|
-
|
8,919,075
x
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-6.42
x
|
-3.25
x
|
-44
x
|
6.43
x
|
FCF Yield
|
-
|
-
|
-
|
-
|
-15.6%
|
-30.8%
|
-2.27%
|
15.6%
|
Price to Book
|
-
|
1.78
x
|
-
|
-
|
0.8
x
|
0.68
x
|
0.66
x
|
0.64
x
|
Nbr of stocks (in thousands)
|
675,939
|
805,309
|
847,929
|
847,944
|
840,806
|
847,949
|
-
|
-
|
Reference price
2 |
10.79
|
16.35
|
16.30
|
9.070
|
8.070
|
7.110
|
7.110
|
7.110
|
Announcement Date
|
15/04/20
|
19/04/21
|
21/04/22
|
20/04/23
|
26/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
8,150
|
7,545
|
-
|
-
|
14,584
|
18,757
|
22,244
|
23,149
|
EBITDA
|
-
|
1,476
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
1,038
|
-
|
-
|
75.51
|
322
|
506
|
673
|
Operating Margin
|
-
|
13.76%
|
-
|
-
|
0.52%
|
1.72%
|
2.27%
|
2.91%
|
Earnings before Tax (EBT)
1 |
-
|
1,052
|
-
|
-
|
86.68
|
332
|
516
|
683
|
Net income
1 |
-
|
889.2
|
934.7
|
249.2
|
137.4
|
332
|
516
|
683
|
Net margin
|
-
|
11.79%
|
-
|
-
|
0.94%
|
1.77%
|
2.32%
|
2.95%
|
EPS
2 |
1.130
|
1.070
|
1.010
|
0.3200
|
0.2100
|
0.3900
|
0.6100
|
0.8000
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
-1,057
|
-1,857
|
-137
|
938
|
FCF margin
|
-
|
-
|
-
|
-
|
-7.25%
|
-9.9%
|
-0.62%
|
4.05%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
137.34%
|
Dividend per Share
2 |
-
|
0.3480
|
-
|
-
|
0.0940
|
0.2300
|
0.3500
|
0.4700
|
Announcement Date
|
15/04/20
|
19/04/21
|
21/04/22
|
20/04/23
|
26/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
-1,057
|
-1,857
|
-137
|
938
|
ROE (net income / shareholders' equity)
|
-
|
13.7%
|
-
|
-
|
1.57%
|
3.7%
|
5.7%
|
7.3%
|
ROA (Net income/ Total Assets)
|
-
|
8.58%
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
10,364
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
9.190
|
-
|
-
|
10.00
|
10.50
|
10.80
|
11.10
|
Cash Flow per Share
|
-
|
1.560
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
2,394
|
-
|
-
|
2,210
|
2,000
|
1,500
|
1,000
|
Capex / Sales
|
-
|
31.73%
|
-
|
-
|
15.16%
|
10.66%
|
6.74%
|
4.32%
|
Announcement Date
|
15/04/20
|
19/04/21
|
21/04/22
|
20/04/23
|
26/04/24
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -11.90% | 834M | | +5.97% | 105B | | -4.19% | 63.99B | | +51.90% | 42.95B | | +17.44% | 39.2B | | +6.62% | 33.01B | | +13.00% | 20.33B | | +15.64% | 17.29B | | +22.55% | 15.72B | | +7.34% | 14.72B |
Other Commodity Chemicals
|